Browsing by Author VASUDEVAN SUBHASH

Select a letter below to browse by last name or type
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z


Showing results 6 to 25 of 49 < previous   next >
Issue DateTitleAuthor(s)
2016Characterization of RyDEN (C19orf66) as an Interferon-Stimulated Cellular Inhibitor against Dengue Virus ReplicationSuzuki Y.; Chin W.-X.; Han Q.; Ichiyama K.; Lee C.H.; Eyo Z.W.; Ebina H.; Takahashi H.; Takahashi C.; Tan B.H.; Hishiki T.; Ohba K.; Matsuyama T.; Koyanagi Y.; Tan Y.-J. ; Sawasaki T.; Chu J.J.H. ; Vasudevan S.G. ; Sano K.; Yamamoto N.
Mar-2014Chikungunya virus nsP3 & nsP4 interacts with HSP-90 to promote virus replication: HSP-90 inhibitors reduce CHIKV infection and inflammation in vivoRathore, A.P.S. ; Haystead, T.; Das, P.K.; Merits, A.; Ng, M.-L.; Vasudevan, S.G. 
2015Comparison of incidence of ptosis after combined phacotrabeculectomy with mitomycin C and phacoemulsificationKoh V. ; Tatsios J. ; Chew P.T.K. ; Amrith S.
2008Decision tree algorithms predict the diagnosis and outcome of dengue fever in the early phase of illnessTanner L.; Schreiber M.; Low J.G.H.; Ong A.; Tolfvenstam T.; Lai Y.L.; Ng L.C.; Leo Y.S.; Puong L.T.; Vasudevan S.G. ; Simmons C.P.; Hibberd M.L.; Ooi E.E. 
Oct-2011Dengue protease activity: The structural integrity and interaction of NS2B with NS3 protease and its potential as a drug targetPhong, W.Y.; Moreland, N.J.; Lim, S.P.; Wen, D.; Paradkar, P.N.; Vasudevan, S.G. 
2007Dengue virus serotype infection specifies the activation of the unfolded protein responseUmareddy I.; Pluquet O.; Wang Q.Y.; Vasudevan S.G. ; Chevet E.; Gu F.
Oct-2009Depletion of macrophages in mice results in higher dengue virus titers and highlights the role of macrophages for virus controlFink, K.; Ng, C.; Nkenfou, C.; Vasudevan, S.G. ; Van Rooijen, N.; Schul, W.
2013Differential unfolded protein response during Chikungunya and Sindbis virus infection: CHIKV nsP4 suppresses eIF2α phosphorylationRathore, A.P.S. ; Ng, M.-L.; Vasudevan, S.G. 
Oct-2012Dose- and schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trialWatanabe, S.; Rathore, A.P.S. ; Sung, C.; Lu, F.; Khoo, Y.M.; Connolly, J.; Low, J.; Ooi, E.E.; Lee, H.S.; Vasudevan, S.G. 
Dec-2012Establishment of a robust dengue virus NS3-NS5 binding assay for identification of protein-protein interaction inhibitorsTakahashi, H.; Takahashi, C.; Moreland, N.J.; Chang, Y.-T. ; Sawasaki, T.; Ryo, A.; Vasudevan, S.G. ; Suzuki, Y.; Yamamoto, N.
Feb-2013Exploring the binding of peptidic West Nile virus NS2B-NS3 protease inhibitors by NMRKang, C.; Gayen, S.; Wang, W.; Severin, R.; Chen, A.S.; Lim, H.A.; Chia, C.S.B.; Schüller, A. ; Doan, D.N.P.; Poulsen, A.; Hill, J.; Vasudevan, S.G. ; Keller, T.H.
Mar-2012Expression and immunoaffinity purification of recombinant dengue virus 2 NS1 protein as a cleavable SUMOstar fusionRozen-Gagnon, K.; Moreland, N.J.; Ruedl, C.; Vasudevan, S.G. 
2016Extended Evaluation of Virological, Immunological and Pharmacokinetic Endpoints of CELADEN: A Randomized, Placebo-Controlled Trial of Celgosivir in Dengue Fever PatientsSung C.; Wei Y.; Watanabe S.; Lee H.S.; Khoo Y.M.; Fan L.; Rathore A.P.S.; Chan K.W.-K.; Choy M.M.; Kamaraj U.S.; Sessions O.M.; Aw P.; de Sessions P.F.; Lee B.; Connolly J.E.; Hibberd M.L.; Vijaykrishna D.; Wijaya L.; Ooi E.E. ; Low J.G.-H.; Vasudevan S.G. 
Nov-2010Fine-tuning DNA/albumin polyelectrolyte interactions to produce the efficient transfection agent cBSA-147Eisele, K.; Gropeanu, R.A.; Zehendner, C.M.; Rouhanipour, A.; Ramanathan, A.; Mihov, G.; Koynov, K.; Kuhlmann, C.R.W.; Vasudevan, S.G. ; Luhmann, H.J.; Weil, T. 
11-Jun-2010Flexibility between the protease and helicase domains of the dengue virus NS3 protein conferred by the linker region and its functional implicationsLuo, D.; Wei, N.; Doan, D.N.; Paradkar, P.N.; Chong, Y.; Davidson, A.D.; Kotaka, M.; Lescar, J.; Vasudevan, S.G. 
May-2009Genomic epidemiology of a dengue virus epidemic in urban SingaporeSchreiber, M.J.; Holmes, E.C.; Swee, H.O.; Soh, H.S.H.; Liu, W.; Tanner, L.; Aw, P.P.K.; Hwee, C.T.; Lee, C.N.; Yee, S.L.; Low, J.G.H.; Ong, A.; Eng, E.O.; Vasudevan, S.G. ; Hibberd, M.L.
Dec-1993Glycosylation and high-level secretion of human tumour necrosis factor-beta in recombinant baculovirus-infected insect cellsChai, H.; Vasudevan, S.G. ; Porter, A.G. ; Chua Kim Lee; Oh, S. ; Yap, M. 
Dec-1993Glycosylation and high-level secretion of human tumour necrosis factor-beta in recombinant baculovirus-infected insect cellsChai, H.; Vasudevan, S.G. ; Porter, A.G. ; Chua Kim Lee; Oh, S. ; Yap, M. 
Nov-2010High affinity human antibody fragments to dengue virus non-structural protein 3Moreland, N.J.; Tay, M.Y.F.; Lim, E.; Paradkar, P.N.; Doan, D.N.P.; Yau, Y.H.; Shochat, S.G.; Vasudevan, S.G. 
2007Host gene expression profiling of dengue virus infection in cell lines and patientsFink J.; Gu F.; Ling L.; Tolfvenstam T.; Olfat F.; Chin K.C.; Aw P.; George J.; Kuznetsov V.A.; Schreiber M.; Vasudevan S.G. ; Hibberd M.L.